Exelixis (EXEL) Asset Utilization Ratio (2011 - 2026)
Exelixis (EXEL) recorded quarterly Asset Utilization Ratio of 0.87 in Q2 2026, up 6.72% quarter-over-quarter from 0.82 in Q1 2026, and up 9.92% on a YoY basis from 0.79 in Q2 2025.
Exelixis (EXEL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Exelixis' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.87 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 9.92% year-over-year to 0.87; the TTM figure through Apr 2026 stood at 0.87 (up 9.92% YoY), while the FY2026 annual figure was 0.8, up 8.79% from the prior year.
- Asset Utilization Ratio was 0.87 for Q2 2026 at Exelixis, up from 0.82 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.87 in Q2 2026 to a low of 0.51 in Q2 2022.
- Historically, Asset Utilization Ratio has averaged 0.67 across 5 years, with a median of 0.64 in 2024.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio decreased 0.39% in 2022, then jumped 32.42% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.53 in 2022, then rose by 15.78% to 0.62 in 2023, then grew by 17.42% to 0.73 in 2024, then rose by 14.56% to 0.83 in 2025, then rose by 5.03% to 0.87 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.87 (Q2 2026), 0.82 (Q1 2026), and 0.83 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 0.55 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 0.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 0.87 |
| Jan 2, 2026 | 0.82 |
| Oct 3, 2025 | 0.83 |
| Jul 4, 2025 | 0.81 |
| Apr 4, 2025 | 0.79 |
| Jan 3, 2025 | 0.73 |
| Sep 27, 2024 | 0.73 |
| Jun 28, 2024 | 0.72 |
| Mar 29, 2024 | 0.64 |
| Dec 29, 2023 | 0.62 |
| Sep 29, 2023 | 0.58 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.54 |
| Dec 30, 2022 | 0.53 |
| Sep 30, 2022 | 0.52 |
| Jul 1, 2022 | 0.54 |
| Apr 1, 2022 | 0.51 |
| Oct 1, 2021 | 0.52 |
| Jul 2, 2021 | 0.51 |
| Apr 2, 2021 | 0.48 |